No Data
No Data
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$150.33K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 10,867 shares of common stock on Jun 12, 13, 2024 at an average price of $13.83 for a total value of $15
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$161.1K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 11,743 shares of common stock on Jun 10, 11, 2024 at an average price of $13.72 for a total value of $16
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$184.08K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 13,361 shares of common stock on Jun 6, 7, 2024 at an average price of $13.78 for a total value of $184.
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$809.22K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 59,440 shares of common stock on Jun 4, 5, 2024 at an average price of $13.61 for a total value of $809.
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$283.99K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 21,369 shares of common stock on May 31, 2024 at an average price of $13.29 for a total value of $283.99
Abrdn Life Sciences Investors(HQL.US) 10% Shareholder Buys US$623.18K in Common Stock
$abrdn Life Sciences Investors(HQL.US)$ 10% Shareholder Saba Capital Management, L.P. purchased 47,416 shares of common stock on May 28, 29, 30, 2024 at an average price of $13.14 for a total value of
No Data